493 related articles for article (PubMed ID: 34638863)
1. Concepts in Oncolytic Adenovirus Therapy.
Mantwill K; Klein FG; Wang D; Hindupur SV; Ehrenfeld M; Holm PS; Nawroth R
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638863
[TBL] [Abstract][Full Text] [Related]
2. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
[TBL] [Abstract][Full Text] [Related]
3. Armed replicating adenoviruses for cancer virotherapy.
Cody JJ; Douglas JT
Cancer Gene Ther; 2009 Jun; 16(6):473-88. PubMed ID: 19197323
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic viruses: adenoviruses.
Niemann J; Kühnel F
Virus Genes; 2017 Oct; 53(5):700-706. PubMed ID: 28702840
[TBL] [Abstract][Full Text] [Related]
5. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
Tyler MA; Ulasov IV; Sonabend AM; Nandi S; Han Y; Marler S; Roth J; Lesniak MS
Gene Ther; 2009 Feb; 16(2):262-78. PubMed ID: 19078993
[TBL] [Abstract][Full Text] [Related]
6. The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model.
Li X; Wang P; Li H; Du X; Liu M; Huang Q; Wang Y; Wang S
Clin Cancer Res; 2017 Jan; 23(1):239-249. PubMed ID: 27435398
[TBL] [Abstract][Full Text] [Related]
7. Modification of oncolytic adenovirus and its application in cancer therapy.
Liang Y; He J; Zhao Y
Discov Med; 2020; 30(161):129-144. PubMed ID: 33593481
[TBL] [Abstract][Full Text] [Related]
8. Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans.
Cerullo V; Koski A; Vähä-Koskela M; Hemminki A
Adv Cancer Res; 2012; 115():265-318. PubMed ID: 23021247
[TBL] [Abstract][Full Text] [Related]
9. Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents.
González-Pastor R; Ashshi AM; El-Shemi AG; Dmitriev IP; Kashentseva EA; Lu ZH; Goedegebuure SP; Podhajcer OL; Curiel DT
J Ovarian Res; 2019 Feb; 12(1):18. PubMed ID: 30767772
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer.
Ashshi AM; El-Shemi AG; Dmitriev IP; Kashentseva EA; Curiel DT
J Ovarian Res; 2016 Jun; 9(1):38. PubMed ID: 27349517
[TBL] [Abstract][Full Text] [Related]
11. Non-Human Primate-Derived Adenoviruses for Future Use as Oncolytic Agents?
Bots STF; Hoeben RC
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650405
[TBL] [Abstract][Full Text] [Related]
12. Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer.
Nettelbeck DM
J Mol Med (Berl); 2008 Apr; 86(4):363-77. PubMed ID: 18214411
[TBL] [Abstract][Full Text] [Related]
13. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
14. Tropism and transduction of oncolytic adenovirus vectors in prostate cancer therapy.
Wu C; Wei FK; Xu ZY; Wen RM; Chen JC; Wang JQ; Mao LJ
Front Biosci (Landmark Ed); 2021 Oct; 26(10):866-872. PubMed ID: 34719211
[TBL] [Abstract][Full Text] [Related]
15. Chapter four--Design of improved oncolytic adenoviruses.
Alemany R
Adv Cancer Res; 2012; 115():93-114. PubMed ID: 23021243
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.
Thaci B; Ahmed AU; Ulasov IV; Tobias AL; Han Y; Aboody KS; Lesniak MS
Cancer Gene Ther; 2012 Jun; 19(6):431-42. PubMed ID: 22555507
[TBL] [Abstract][Full Text] [Related]
17. A qPCR-Based Method for Quantification of Replication Competent Adenovirus (RCA) in Conditionally Replicating Oncolytic Adenoviruses.
Yngve E; Gao M; Yu D
Methods Mol Biol; 2022; 2521():249-258. PubMed ID: 35733002
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in genetic modification of adenovirus vectors for cancer treatment.
Yamamoto Y; Nagasato M; Yoshida T; Aoki K
Cancer Sci; 2017 May; 108(5):831-837. PubMed ID: 28266780
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.
Palmer DH; Chen MJ; Searle PF; Kerr DJ; Young LS
Gene Ther; 2005 Aug; 12(15):1187-97. PubMed ID: 15800660
[TBL] [Abstract][Full Text] [Related]
20. Evolving Status of Clinical Immunotherapy with Oncolytic Adenovirus.
Farrera-Sal M; Moya-Borrego L; Bazan-Peregrino M; Alemany R
Clin Cancer Res; 2021 Jun; 27(11):2979-2988. PubMed ID: 33526422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
